WO2004020457A3 - Methods and compositions for the inhibition of dna repair protein xrcc-3 - Google Patents

Methods and compositions for the inhibition of dna repair protein xrcc-3 Download PDF

Info

Publication number
WO2004020457A3
WO2004020457A3 PCT/US2003/027321 US0327321W WO2004020457A3 WO 2004020457 A3 WO2004020457 A3 WO 2004020457A3 US 0327321 W US0327321 W US 0327321W WO 2004020457 A3 WO2004020457 A3 WO 2004020457A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
inhibition
dna repair
repair protein
Prior art date
Application number
PCT/US2003/027321
Other languages
French (fr)
Other versions
WO2004020457A2 (en
Inventor
Philip Connell
Douglas Bishop
Ralph Weichselbaum
Original Assignee
Philip Connell
Douglas Bishop
Ralph Weichselbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Connell, Douglas Bishop, Ralph Weichselbaum filed Critical Philip Connell
Priority to AU2003268340A priority Critical patent/AU2003268340A1/en
Publication of WO2004020457A2 publication Critical patent/WO2004020457A2/en
Publication of WO2004020457A3 publication Critical patent/WO2004020457A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Methods and compositions comprising peptides derived from Rad51C.
PCT/US2003/027321 2002-08-30 2003-08-29 Methods and compositions for the inhibition of dna repair protein xrcc-3 WO2004020457A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003268340A AU2003268340A1 (en) 2002-08-30 2003-08-29 Methods and compositions for the inhibition of dna repair protein xrcc-3

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40755702P 2002-08-30 2002-08-30
US60/407,557 2002-08-30
US41114702P 2002-09-16 2002-09-16
US60/411,147 2002-09-16

Publications (2)

Publication Number Publication Date
WO2004020457A2 WO2004020457A2 (en) 2004-03-11
WO2004020457A3 true WO2004020457A3 (en) 2005-02-17

Family

ID=31981526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/027321 WO2004020457A2 (en) 2002-08-30 2003-08-29 Methods and compositions for the inhibition of dna repair protein xrcc-3

Country Status (2)

Country Link
AU (1) AU2003268340A1 (en)
WO (1) WO2004020457A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013094699A1 (en) 2011-12-20 2013-06-27 東亞合成株式会社 Method for producing multipolar cells
JP6156698B2 (en) * 2011-12-20 2017-07-05 東亞合成株式会社 Anti-tumor peptide and use thereof
US9353350B2 (en) 2011-12-20 2016-05-31 Toagosei Co. Ltd. Method for producing multipolar cell
US9393250B2 (en) 2012-04-12 2016-07-19 University Of Saskatchewan Phthalocyanine compounds useful as RecA inhibitors and methods of using same
GB2584210B (en) * 2017-11-22 2022-03-16 Synthex Inc Peptides for inhibiting RAD51

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COLLINS ET AL.: "Ribozyme minigene-mediated RAD51 down regulation increases radiosensitivity of human prostate cancer cells", NUCLEIC ACIDS RESEARCH, vol. 29, no. 7, 2001, pages 1534 - 1538, XP002983517 *

Also Published As

Publication number Publication date
WO2004020457A2 (en) 2004-03-11
AU2003268340A1 (en) 2004-03-19
AU2003268340A8 (en) 2004-03-19

Similar Documents

Publication Publication Date Title
WO2003093441A3 (en) A method of regulating gene expression
WO2005047511A3 (en) Bacterial expression of protease inhibitors and variants thereof
WO2005115431A3 (en) Methods for inhibiting proteasome and heat shock protein 90
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
AU2003270310A1 (en) Compositions and methods for synthesizing nucleic acids
WO2007087053A3 (en) Bmp-7 variant compositions, methods and uses
AU2003257109A1 (en) Compositions and methods for molecular biology
WO2004087073A3 (en) Treatment of demyelinating conditions
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2003234198A1 (en) Novel genes, compositions, and methods for modulating the unfolded protein response
WO2004011605A3 (en) Hybrid protein methods and compositions
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
AU2003304180A1 (en) Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
WO2002068476A3 (en) Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
WO2004003149A8 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
WO2004020457A3 (en) Methods and compositions for the inhibition of dna repair protein xrcc-3
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2004050613A3 (en) 2-substituted-3-propenamide derivatives and methods of using the same
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
WO2004026892A3 (en) Fragmentation of dna
WO2004019965A3 (en) Thymus-based tolerogenic approaches for type i diabetes.
WO2005059101A3 (en) Novel sodium channel
WO2004006864A3 (en) Methods and compositions for the enhancement of wound healing
EP1494712A4 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP